SILEXION THERAPEUTICS CORP Proceeds from Sale of Investment Projects
SILEXION THERAPEUTICS CORP (SLXN) had Proceeds from Sale of Investment Projects of $538.00 thousand as of 2023-05-30, per its 8-K filed 2025-08-20.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfInvestmentProjects · last filed 2025-08-20
- 2023-05-30: Proceeds from Sale of Investment Projects $538.00K.
| Period end | Proceeds from Sale of Investment Projects |
|---|---|
| 2023-05-30 | $538.00K 8-K · filed 2025-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |